Linguamatics’ I2E Text Mining Platform Chosen by FDA

Linguamatics’ I2E Text Mining Platform Chosen by FDA

Linguamatics

Linguamatics, the leader in natural language processing (NLP)-based text mining, announced today that the FDA’s Center for Drug Evaluation and Research (CDER) has licensed its I2E text mining platform to support laboratory research efforts on drug safety. Financial details of the agreement were not disclosed.

During the term of the license, CDER will use I2E to mine published literature and drug product labels to answer questions relating to a range of biomedical topics, including drug toxicity mechanisms and disease processes.

I2E’s NLP-based querying capabilities, coupled with its scalability and flexibility, mean it is ideally suited to answering many challenging, high value questions in life sciences and healthcare by unlocking knowledge buried in the scientific literature and other textual information. Rather than just retrieving documents, I2E can rapidly identify, extract, synthesize and analyze specific, relevant facts and relationships, such as those between genes and diseases or compounds and side effects. Customers include nine of the top ten global pharmaceutical companies.

“We are very pleased to welcome CDER/FDA as a customer”, commented John Brimacombe, Executive Chairman at Linguamatics. “Their adoption of the I2E text mining platform reflects the continued growth in demand for NLP-based text mining as a key knowledge discovery and decision support tool in the pharmaceutical, biotechnology and healthcare sectors.”

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services.

The FDA consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods, Global Regulatory Operations and Policy, and Operations.

For more information, visit .

Linguamatics is the world leader in deploying innovative natural language processing (NLP)-based text mining for high-value knowledge discovery and decision support and is used by top commercial, academic and government organizations, including nine of the top ten global pharmaceutical companies. I2E is available as an in-house enterprise system and as software as a service on the cloud.

Typical applications in pharmaceuticals, biotechnology and healthcare include:

Business intelligence applications include social media mining and sentiment analysis.

For further information, visit .

For new and experienced users of Linguamatics and other text mining software or any professionals interested in the mining and analysis of textual information. Includes user presentations, insights on practical approaches to text mining and knowledge discovery, round table discussions, networking, partner exhibits and hands-on training workshops.

For more information or to register, visit .

Suggested Articles

Cancer biotech Zentalis Pharmaceuticals priced its IPO at $165 million, eclipsing the $100 million goal it laid out in early March.

The agreement gives Innovax access to a GSK adjuvant to enhance the immune response triggered by its recombinant protein-based vaccine.

Johnson & Johnson is paying Fate Therapeutics $50 million upfront to collaborate on up to four CAR NK and CAR-T cell therapies.